Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Genesee & Wyoming Reports Results for the First Quarter of 2019

Published

on

Reading Time: 13 minutes

DARIEN, Conn.–(BUSINESS WIRE)–Genesee & Wyoming Inc. (G&W) (NYSE:GWR)

First Quarter 2019 Consolidated Highlights Compared with First
Quarter 2018

  • Operating revenues decreased 2.9% to $558.1 million from $574.7
    million.
  • Reported operating income decreased 8.3% to $79.7 million; Adjusted
    operating income increased 0.5% to $87.8 million despite negative
    effects from severe winter weather and flooding in North America.(1)
  • Reported diluted earnings per common share (EPS) decreased 42.9% to
    $0.68 with 57.1 million weighted average shares outstanding, compared
    with reported diluted EPS in the first quarter of 2018 of $1.19 with
    62.9 million weighted average shares outstanding; Adjusted diluted EPS
    increased 11.4% to $0.78.(1)
  • Reported net income and diluted EPS for the first quarter of 2019
    included $5.4 million, or $0.10 per share, of restructuring and
    related costs. Reported net income and diluted EPS for the first
    quarter of 2018 included a $31.6 million, or $0.50 per share, income
    tax benefit associated with the U.S. Short Line Tax Credit for fiscal
    year 2017 that was enacted retroactively in February 2018.

Company Comments

Jack Hellmann, Chairman and Chief Executive Officer of G&W, commented,
“In the first quarter of 2019, our adjusted diluted EPS increased over
11%, despite severe winter weather and flooding in North America that
impeded shipments from connecting Class I railroads to our Midwest and
Canada regions. These weather impacts resulted in a $0.09, or 10%,
reduction in diluted EPS compared with our first quarter guidance. We
expect to recover a portion of the winter-affected traffic in the coming
months, our outlook for North American rail shipments remains positive
and our 2019 annual guidance remains unchanged.”

“In the first quarter of 2019, we implemented cost reduction initiatives
in each of our three geographic segments. In North America, we
consolidated our Central Region into our Midwest and Southern regions.
In the U.K./Europe, we continued to make reductions in our overhead cost
structure and to invest in technology, and in Australia, we streamlined
rail operations concurrent with the termination of grain operations on
the Eyre Peninsula narrow gauge network.”

“Finally, in the first quarter of 2019, we evaluated several potential
acquisitions and investments. And in March, we signed two long-term
leases of short line railroads in Indiana that create a contiguous
400-mile, four-railroad footprint (CERA-TPW-TZPR-IMRR) within our
Midwest Region, spanning from Eastern Indiana to Western Illinois with
connections to six Class I railroads.”

First Quarter Segment Highlights

  • North America: Operating revenues from G&W’s North American Operations
    increased 2.1% to $332.4 million from $325.6 million. Revenue for the
    first quarter of 2018 included $5.5 million of revenues from leased
    railroads in Canada, for which the leases expired at the end of 2018.
    Reported operating income from G&W’s North American Operations, which
    was negatively impacted by severe winter weather in the United States
    and Canada and flooding in the Midwestern United States, decreased
    5.3% to $69.3 million; Adjusted operating income from G&W’s North
    American Operations decreased 4.2% to $70.3 million.(1)
  • Australia: Operating revenues from G&W’s 51.1% owned Australian
    Operations decreased 13.0% to $65.1 million from $74.8 million.
    Reported operating income from G&W’s Australian Operations decreased
    21.7% to $12.5 million; Adjusted operating income from G&W’s
    Australian Operations decreased 11.9% to $14.1 million. Operating
    income from G&W’s Australian Operations were negatively impacted by
    $1.5 million from foreign currency depreciation and $1.5 million from
    drought conditions in South Australia and New South Wales, which were
    partially offset by a decrease in expenses.(1)
  • U.K./Europe: Operating revenues from G&W’s U.K./European Operations
    decreased 7.8% to $160.5 million from $174.2 million. Revenues for the
    first quarter of 2018 included $14.7 million of revenues from G&W’s
    former Continental Europe intermodal business, ERS Railways B.V.
    (ERS), which was sold in June 2018. Reported operating loss from G&W’s
    U.K./European Operations remained relatively flat at $2.1 million.
    Adjusted operating income from G&W’s U.K./European Operations
    increased to $3.4 million from an adjusted operating loss of $2.0
    million in 2018.(1)

Financial Results

G&W’s operating revenues decreased $16.6 million, or 2.9%, to $558.1
million in the first quarter of 2019, compared with $574.7 million in
the first quarter of 2018. G&W’s operating income in the first quarter
of 2019 was $79.7 million, compared with $86.9 million in the first
quarter of 2018. Excluding certain items affecting comparability between
periods discussed below, G&W’s adjusted operating income in the first
quarter of 2019 was $87.8 million, compared with $87.4 million in the
first quarter of 2018.(1)

G&W’s provision for income taxes in the first quarter of 2019 was $14.3
million, while the benefit from income taxes for the first quarter of
2018 was $15.9 million. G&W’s effective tax rate for the first quarter
of 2019 was 26.9%, compared with 26.2% in the first quarter of 2018,
excluding the $31.6 million income tax benefit from the retroactive
extension of the of the U.S. Short Line Tax Credit for fiscal year 2017
that was enacted in February 2018.

Reported net income attributable to G&W in the first quarter of 2019 was
$38.7 million, compared with reported net income attributable to G&W of
$75.1 million in the first quarter of 2018. Excluding the net impact of
certain items affecting comparability between periods discussed below,
G&W’s adjusted net income attributable to G&W in the first quarter of
2019 was $44.4 million, compared with $43.8 million in the first quarter
of 2018.(1)

G&W’s reported diluted EPS in the first quarter of 2019 were $0.68 with
57.1 million weighted average shares outstanding, compared with reported
diluted EPS in the first quarter of 2018 of $1.19 with 62.9 million
weighted average shares outstanding. G&W’s adjusted diluted EPS in the
first quarter of 2019 were $0.78 with 57.1 million weighted average
shares outstanding, compared with adjusted diluted EPS in the first
quarter of 2018 of $0.70 with 62.9 million weighted average shares
outstanding.(1)

Items Affecting Comparability

In the first quarter of 2019 and 2018, G&W’s results included certain
items affecting comparability between the periods that are set forth in
the following table (in millions, except per share amounts):

               

Income/(Loss)
Before Income
Taxes
Impact

After-Tax Net
Income/(Loss)
Attributable
to

G&W Impact

Diluted EPS
Impact

Three Months Ended March 31, 2019

Corporate development and related costs $ (0.4 ) $ (0.3 ) $ (0.01 )
Restructuring and related costs $ (7.6 ) $ (5.4 ) $ (0.10 )
 

Three Months Ended March 31, 2018

Corporate development and related costs $ (0.2 ) $ (0.1 ) $
Restructuring and related costs $ (0.3 ) $ (0.2 ) $
2017 Short Line Tax Credit $ $ 31.6 $ 0.50
 

In the first quarter of 2019, G&W’s results included restructuring and
related costs of $7.6 million, primarily driven by our optimization
activities in the U.K., and corporate development and related costs of
$0.4 million.

In the first quarter of 2018, G&W’s results included a $31.6 million
income tax benefit associated with the U.S. Short Line Tax Credit for
fiscal year 2017 that was enacted in February 2018.

First Quarter Results by Segment

Operating revenues from G&W’s North American Operations increased $6.8
million, or 2.1%, to $332.4 million in the first quarter of 2019,
compared with $325.6 million in the first quarter of 2018. Excluding
$5.5 million of revenues from lease expirations in Canada for the first
quarter of 2018 and a $1.1 million decrease due to the impact of foreign
currency depreciation, North American Operations same railroad revenues
increased $13.3 million, or 4.2%, primarily due to increases in freight
and freight-related revenues.

G&W’s North American Operations were negatively impacted by extreme
winter weather in the United States and Canada and flooding in the
Midwestern United States. Operating income from G&W’s North American
Operations was $69.3 million in the first quarter of 2019, compared with
$73.2 million in the first quarter of 2018. The operating ratio for
North American Operations was 79.1% in the first quarter of 2019,
compared with 77.5% in the first quarter of 2018. Adjusted operating
income from G&W’s North American Operations in the first quarter of 2019
was $70.3 million, compared with $73.4 million in the first quarter of
2018. The adjusted operating ratio for North American Operations was
78.9% in the first quarter of 2019, compared with an adjusted operating
ratio of 77.5% in the first quarter of 2018.(1)

Operating revenues from G&W’s Australian Operations decreased $9.7
million, or 13.0%, to $65.1 million in the first quarter of 2019,
compared with $74.8 million in the first quarter of 2018. Excluding a
$7.0 million decrease due to the impact of foreign currency
depreciation, Australian Operations revenues decreased $2.7 million, or
4.0%, primarily due to decreases in drought impacted agricultural
products freight revenues and freight-related revenues.(2)

G&W’s Australian Operations had operating income of $12.5 million in the
first quarter of 2019, compared with $16.0 million in the first quarter
of 2018. The operating ratio for Australian Operations was 80.8% in the
first quarter of 2019, compared with 78.7% in the first quarter of 2018.
Adjusted operating income from G&W’s Australian Operations was $14.1
million in the first quarter of 2019, compared with $16.0 million in the
first quarter of 2018. The adjusted operating ratio for Australian
Operations was 78.4% in the first quarter of 2019, compared with 78.6%
in the first quarter of 2018. Operating income from G&W’s Australian
Operations was negatively impacted by $1.5 million from foreign currency
depreciation and $1.5 million from drought conditions in South Australia
and New South Wales, which were partially offset by a decrease in
expenses.(1)

Operating revenues from G&W’s U.K./European Operations decreased $13.7
million, or 7.8%, to $160.5 million in the first quarter of 2019,
compared with $174.2 million in the first quarter of 2018. Excluding
$14.7 million of revenues from G&W’s divested ERS operations for the
first quarter of 2018 and an $11.0 million decrease due to the impact of
foreign currency depreciation, U.K./European Operations same railroad
revenues increased $12.1 million, or 8.1%, primarily due to increases in
U.K. intermodal freight-related and freight revenues.(2)

G&W’s U.K./European Operations had an operating loss of $2.1 million in
the first quarter of 2019, compared with and operating loss of $2.2
million in the first quarter of 2018, which included operating income of
$0.5 million from ERS. The operating ratio for G&W’s U.K./European
Operations of 101.3% in the first quarter of 2019 remained unchanged
compared with the first quarter of 2018. Adjusted operating income from
G&W’s U.K./European Operations was $3.4 million in the first quarter of
2019, compared with an adjusted operating loss of $2.0 million in the
first quarter of 2018, which included operating income of $0.5 million
from ERS. The adjusted operating ratio for U.K./European Operations was
97.9% in the first quarter of 2019, compared with 101.2% in the first
quarter of 2018.(1)

Adjusted Free Cash Flow Measures (1)

Adjusted free cash flow measures for the three months ended March 31,
2019 and 2018 were as follows (in millions):

     
Three Months Ended
March 31,
2019     2018
Net cash provided by operating activities $ 103.4 $ 101.4
Allocation of adjusted cash flow to noncontrolling interest(a) (7.1 ) (9.0 )
Adjusted net cash provided by operating activities attributable to
G&W
$ 96.3 $ 92.4
Core capital expenditures(b) (59.5 ) (41.4 )
Adjusted free cash flow attributable to G&W before new business
investments and grant funded projects
$ 36.8 $ 51.0
New business investments (1.6 ) (7.5 )
Grant funded projects, net of proceeds received from outside parties(c) 2.4   (0.4 )
Adjusted free cash flow attributable to G&W $ 37.6   $ 43.1  
 
(a)   Allocation of adjusted cash flow to noncontrolling interest
(Macquarie Infrastructure and Real Assets’ (MIRA’s) 48.9% equity
ownership of G&W Australia Holdings LP (GWA) since December 1, 2016)
is calculated as 48.9% of the total of (i) cash flow provided by
operating activities of G&W’s Australian Operations, less (ii) net
purchases of property and equipment of G&W’s Australian Operations.
The timing and amount of actual distributions, if any, from GWA to
G&W and MIRA made in any given period will vary and could differ
materially from the amounts presented. No such distributions were
made for the three months ended March 31, 2019 and 2018. G&W
expressly disclaims any direct correlation between the allocation of
adjusted cash flow to noncontrolling interest and actual
distributions made in any given period.
(b) Core capital expenditures represent purchases of property and
equipment as presented on the Statement of Cash Flows less grant
proceeds from outside parties, insurance proceeds for the
replacement of assets and proceeds from disposition of property and
equipment, each of which as presented on the Statement of Cash
Flows, less new business investments and grant funded projects.
(c) Grant funded projects represent purchases of property and equipment
for projects partially or entirely funded by outside parties, net of
grant proceeds from outside parties as presented on the Statement of
Cash Flows.
 

Share Repurchase Program

During the first quarter of 2019, G&W repurchased 64,860 shares of Class
A Common Stock for $4.8 million, which resulted in a reduction of 59,095
shares in our weighted average diluted shares outstanding for the first
quarter of 2019. During the first quarter of 2018, G&W repurchased
792,921 shares of Class A Common Stock for $57.4 million, which resulted
in a reduction of 51,106 shares in our weighted average diluted shares
outstanding for the first quarter of 2018.

Conference Call and Webcast Details

As previously announced, G&W’s conference call to discuss financial
results for the first quarter of 2019 will be held on Tuesday, April 30,
2019, at 11 a.m. EDT. The dial-in number for the teleconference in the
U.S. is (800) 230-1085; outside the U.S., the dial-in number is (612)
288-0329, or the call may be accessed live over the Internet (listen
only) at www.gwrr.com/investors.
Management will be referring to a slide presentation that will also be
available at gwrr.com/investors. The webcast will be archived at www.gwrr.com/investors
until the following quarter’s earnings press release. Telephone replay
is available for 30 days beginning at 1 p.m. EDT on April 30, 2019, by
dialing (800) 475-6701 (or outside the U.S., dialing 320-365-3844). The
access code is 458667.

About G&W

G&W owns or leases 120 freight railroads organized in eight locally
managed operating regions with 8,000 employees serving 3,000 customers.

  • G&W’s six North American regions serve 41 U.S. states and four
    Canadian provinces and include 114 short line and regional freight
    railroads with more than 13,000 track-miles.
  • G&W’s Australia Region serves New South Wales, the Northern Territory
    and South Australia and operates the 1,400-mile Tarcoola-to-Darwin
    rail line. The Australia Region is 51.1% owned by G&W and 48.9% owned
    by a consortium of funds and clients managed by Macquarie
    Infrastructure and Real Assets.
  • G&W’s U.K./Europe Region includes the U.K.’s largest rail maritime
    intermodal operator and second-largest freight rail provider, as well
    as regional services in Continental Europe.

G&W subsidiaries and joint ventures also provide rail service at more
than 40 major ports, rail-ferry service between the U.S. Southeast and
Mexico, transload services, contract coal loading, and industrial
railcar switching and repair.

From time to time, we may use our website as a channel of distribution
of material company information. Financial and other material
information regarding G&W is routinely posted on and accessible at www.gwrr.com/investors.
In addition, you may automatically receive email alerts and other
information about us by enrolling your email address in the “Email
Alerts” section of www.gwrr.com/investors.
The information contained on or connected to our Internet website is not
deemed to be incorporated by reference in this press release or filed
with the United States Securities and Exchange Commission.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains forward-looking statements regarding future
events and the future performance of Genesee & Wyoming Inc. that are
based on current expectations, estimates and projections about our
industry, management’s beliefs and assumptions made by management. Words
such as “anticipates,” “intends,” “plans,” “believes,” “could,”
“should,” “seeks,” “expects,” “will,” “estimates,” “trends,” “outlook,”
variations of these words and similar expressions are intended to
identify these forward-looking statements. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to forecast, including
the following: risks related to the operation of our railroads; severe
weather conditions and other natural occurrences, which could result in
shutdowns, derailments, railroad network and port congestion or other
substantial disruption of operations; customer demand and changes in our
operations or loss of important customers; exposure to the credit risk
of customers and counterparties; changes in commodity prices;
consummation and integration of acquisitions; economic, political and
industry conditions, including employee strikes or work stoppages;
retention and contract continuation; legislative and regulatory
developments, including changes in environmental and other laws and
regulations to which we or our customers are subject; increased
competition in relevant markets; funding needs and financing sources,
including our ability to obtain government funding for capital projects;
international complexities of operations, currency fluctuations,
finance, tax and decentralized management; challenges of managing rapid
growth, including retention and development of senior leadership;
unpredictability of fuel costs; susceptibility to and outcome of various
legal claims, lawsuits and arbitrations; increase in, or volatility
associated with, expenses related to estimated claims, self-insured
retention amounts and insurance coverage limits; consummation of new
business opportunities; decrease in revenues and/or increase in costs
and expenses; susceptibility to the risks of doing business in foreign
countries; uncertainties arising from a referendum in which voters in
the United Kingdom (U.K.) approved an exit from the European Union
(E.U.), commonly referred to as Brexit; our ability to integrate
acquired businesses successfully or to realize the expected synergies
associated with acquisitions; risks associated with our substantial
indebtedness; failure to maintain satisfactory working relationships
with partners in Australia; failure to maintain an effective system of
internal control over financial reporting as well as disclosure controls
and procedures and other risks including, but not limited to, those
noted in our 2018 Annual Report on Form 10-K and our Quarterly Reports
on Form 10-Q under “Risk Factors.” Therefore, actual results may differ
materially from those expressed or forecasted in any such
forward-looking statements. Forward-looking statements speak only as of
the date of this press release or as of the date they were made. G&W
does not undertake, and expressly disclaims, any duty to publicly update
any forward-looking statement, whether as a result of new information,
future events, or otherwise, except as required by law.

1.   Adjusted operating income, adjusted operating ratio, adjusted net
income attributable to G&W, adjusted diluted earnings per common
share (EPS), and the adjusted free cash flow measures of adjusted
net cash provided by operating activities attributable to G&W,
adjusted free cash flow attributable to G&W and adjusted free cash
flow attributable to G&W before new business investments and grant
funded projects are non-GAAP financial measures and are not intended
to replace financial measures calculated in accordance with GAAP.
The information required by Item 10(e) of Regulation S-K under the
Securities Act of 1933 and the Securities Exchange Act of 1934 and
Regulation G under the Securities Exchange Act of 1934, including a
reconciliation to their most directly comparable financial measures
calculated in accordance with GAAP, is included in the tables
attached to this press release.
 
2. Foreign exchange impact is calculated by comparing the prior period
results translated from local currency to U.S. dollars using current
period exchange rates to the prior period results in U.S. dollars as
reported.
 
 
GENESEE & WYOMING INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 2019 AND 2018
(in thousands, except per share amounts)
(unaudited)
         
Three Months Ended
March 31,
2019 2018
OPERATING REVENUES $ 558,089 $ 574,661
OPERATING EXPENSES 478,379   487,748  
OPERATING INCOME 79,710 86,913
INTEREST INCOME 547 498
INTEREST EXPENSE (27,610 ) (25,236 )
OTHER INCOME/(LOSS), NET 419   (2,040 )
INCOME BEFORE INCOME TAXES 53,066 60,135
(PROVISION FOR)/BENEFIT FROM INCOME TAXES (14,260 ) 15,890  
NET INCOME $ 38,806 $ 76,025
LESS: NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTEREST 100   927  
NET INCOME ATTRIBUTABLE TO GENESEE & WYOMING INC. $ 38,706   $ 75,098  
BASIC EARNINGS PER COMMON SHARE ATTRIBUTABLE TO GENESEE & WYOMING
INC. COMMON STOCKHOLDERS:
$ 0.69   $ 1.21  
WEIGHTED AVERAGE SHARES – BASIC 56,368   61,918  
DILUTED EARNINGS PER COMMON SHARE ATTRIBUTABLE TO GENESEE & WYOMING
INC. COMMON STOCKHOLDERS:
$ 0.68   $ 1.19  
WEIGHTED AVERAGE SHARES – DILUTED 57,132   62,887  
 
 
GENESEE & WYOMING INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
AS OF MARCH 31, 2019 AND DECEMBER 31, 2018
(in thousands)
(unaudited)
         
March 31, December 31,
2019 2018
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 70,108 $ 90,387
Accounts receivable, net 439,527 426,305
Materials and supplies 59,368 56,716
Prepaid expenses and other 66,125   54,185
Total current assets 635,128   627,593
PROPERTY AND EQUIPMENT, net 4,643,936 4,613,014
GOODWILL 1,120,212 1,115,849
INTANGIBLE ASSETS, net 1,429,602 1,430,197
DEFERRED INCOME TAX ASSETS, net 5,261 4,616
OTHER ASSETS, net(a) 547,669   77,192
Total assets $ 8,381,808   $ 7,868,461
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Current portion of long-term debt $ 26,522 $ 28,303
Accounts payable 282,917 288,070
Accrued expenses(a) 232,731   165,280
Total current liabilities 542,170   481,653
LONG-TERM DEBT, less current portion 2,391,695 2,425,235
DEFERRED INCOME TAX LIABILITIES, net 886,183 877,721
DEFERRED ITEMS – grants from outside parties 328,347 326,520
OTHER LONG-TERM LIABILITIES(a) 576,133 127,280
TOTAL EQUITY 3,657,280   3,630,052
Total liabilities and equity $ 8,381,808   $ 7,868,461
(a)   On January 1, 2019, G&W adopted Accounting Standards Update (ASU)
2016-02, Leases. The new standard requires lessees to recognize
operating leases on their balance sheet as a right-of-use asset with
a corresponding lease liability. This resulted in approximately $495
million of assets and a corresponding amount of liabilities being
recognized on G&W’s balance sheet as of March 31, 2019. Capital
leases will continue to be recognized on the balance sheet but are
now referred to as “finance” leases, as required by the new standard.
 

Contacts

Michael Williams of G&W Corporate Communications
1-203-202-8900
[email protected]

Read full story here


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading

Cannabis

Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania